世界の抗菌薬感受性検査（AST）市場は、2023年に34億2,000万米ドルと評価され、2032年までに53億5,000万米ドルに達すると予測されており、2024年から2032年までの予測期間中に5.1%という堅調なCAGRで成長すると予測されています。AST は、抗生物質の過剰使用と誤用によって引き起こされる世界的な健康危機の増大である抗菌薬耐性（AMR）と闘う上で極めて重要な役割を果たしています。この検査方法により、医療提供者は最も効果的な抗菌療法を特定し、治療の失敗や耐性病原体の蔓延を最小限に抑えることができます。
市場の拡大は、薬剤耐性感染症の発生率の上昇と、オーダーメイドの治療にはASTのような正確な診断ソリューションが求められる個別化医療への注目の高まりによって推進されています。抗生物質耐性菌対策（CARB）のための米国国家行動計画や世界的な抗生物質耐性および使用状況監視システム（GLASS） などの政府の取り組みにより、ASTテクノロジーの導入がさらに強化されています。これらの取り組みは、診断および治療戦略の改善を通じてAMRを削減するという世界的な取り組みを反映しています。
特に自動化されたASTシステムにおける技術の進歩により、業界の状況が再構築されています。自動化されたシステムは、手動による方法と比較して、精度が高く、エラーが減少し、所要時間が短縮されます。数時間以内に結果を提供できる迅速なASTソリューションなどの最近のイノベーションにより、臨床現場や研究現場での導入が加速しています。 NanoSynex Ltd.社やCOPAN Diagnostics社などの企業が最前線で次世代ASTツールを市場に導入しています。
地域の力学から、先進的な医療インフラ、多剤耐性感染症の高い蔓延、研究開発への多額の投資に支えられた北アメリカ支配的な市場であることが明らかになりました。一方、アジア太平洋地域は、医療費の増加、AMRに対する意識の高まり、医療システムの近代化への取り組みにより、最も急速な成長を示すと予想されています。ヨーロッパもまた、支援政策や技術革新への注力の恩恵を受けて重要な役割を果たしています。
目次
Table of Content
Chapter 1. Global Antimicrobial Susceptibility Testing Market Executive Summary
1.1. Global Antimicrobial Susceptibility Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technique
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Antimicrobial Susceptibility Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antimicrobial Susceptibility Testing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of antimicrobial resistance
3.1.2. Advancements in personalized medicine
3.1.3. Favorable government policies to combat AMR
3.2. Market Challenges
3.2.1. High costs of advanced AST systems
3.2.2. Limited standardization in AST techniques
3.3. Market Opportunities
3.3.1. Expansion of rapid AST technologies
3.3.2. Rising investments in healthcare infrastructure, especially in APAC
Chapter 4. Global Antimicrobial Susceptibility Testing Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Disruptive Trends
4.5. Industry Expert Perspectives
Chapter 5. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Manual Tests
5.2.1. MIC Strips
5.2.2. Susceptibility Testing Disks
5.2.3. Susceptibility Plates
5.3. Automated Instruments
5.4. Consumables & Media
Chapter 6. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Technique (2022-2032)
6.1. Segment Dashboard
6.2. Disk Diffusion
6.3. Automated AST
6.4. Etest Method
6.5. Others
Chapter 7. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Application (2022-2032)
7.1. Segment Dashboard
7.2. Drug Development
7.3. Susceptibility Testing
7.4. Others
Chapter 8. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by End-Use (2022-2032)
8.1. Segment Dashboard
8.2. Hospitals
8.3. Diagnostic Laboratories
8.4. Biotechnology & Pharmaceutical Companies
8.5. Others
Chapter 9. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Region (2022-2032)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Sweden
9.2.7. Norway
9.2.8. Denmark
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. BD (Becton, Dickinson, and Company)
10.1.3. bioMérieux SA
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific Inc.
10.3.2. BD (Becton, Dickinson, and Company)
10.3.3. Danaher Corporation
10.3.4. Bio-Rad Laboratories Inc.
10.3.5. Merck & Co., Inc.
10.3.6. Siemens Healthineers
10.3.7. Creative Diagnostics
10.3.8. COPAN Diagnostics Inc.
10.3.9. ELITechGroup
10.3.10. Hi-Media Laboratories Pvt. Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.2. Research Attributes
List of Tables
1. Global Antimicrobial Susceptibility Testing Market Size & Forecast, 2022-2032 (USD Billion)
2. North America Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022-2032 (USD Million)
3. Europe Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022-2032 (USD Million)
4. Asia-Pacific Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022-2032 (USD Million)
5. Latin America Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022-2032 (USD Million)
6. Middle East & Africa Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022-2032 (USD Million)
7. Market Segmentation by Product, 2022-2032 (USD Million)
8. Manual Tests Market Size & Forecast, 2022-2032 (USD Million)
9. Automated Instruments Market Size & Forecast, 2022-2032 (USD Million)
10. Consumables & Media Market Size & Forecast, 2022-2032 (USD Million)
11. Market Segmentation by Technique, 2022-2032 (USD Million)
12. Disk Diffusion Market Size & Forecast, 2022-2032 (USD Million)
13. Automated AST Market Size & Forecast, 2022-2032 (USD Million)
14. Etest Method Market Size & Forecast, 2022-2032 (USD Million)
15. Market Segmentation by Application, 2022-2032 (USD Million)
16. Drug Development Market Size & Forecast, 2022-2032 (USD Million)
17. Susceptibility Testing Market Size & Forecast, 2022-2032 (USD Million)
18. End-Use Market Segmentation by Hospitals, 2022-2032 (USD Million)
19. Biotechnology & Pharmaceutical Companies Market Size & Forecast, 2022-2032 (USD Million)
20. List of Major Market Players and Market Share Analysis (2023)
This list is not complete; the final report contains over 100 tables. The list may be updated in the final deliverable.
List of Figures
1. Global Antimicrobial Susceptibility Testing Market Trends, 2022-2032
2. Market Segmentation by Product, 2023 (Share %)
3. Regional Analysis of Antimicrobial Susceptibility Testing Market, 2023 (Share %)
4. Market Segmentation by Technique, 2023 (Share %)
5. Automated Instruments Growth Rate (CAGR) by Region, 2024-2032
6. Technological Advancements in AST Systems, 2023 Overview
7. North America Antimicrobial Susceptibility Testing Market, Historical vs. Forecast, 2022-2032
8. APAC Antimicrobial Susceptibility Testing Market Growth Potential, 2023-2032
9. Porter’s Five Forces Analysis of the AST Market, 2023
10. PESTEL Analysis of Antimicrobial Susceptibility Testing Market, 2023
11. Competitive Market Share Analysis, 2023
12. SWOT Analysis of Thermo Fisher Scientific Inc.
13. SWOT Analysis of BD (Becton, Dickinson, and Company)
14. SWOT Analysis of bioMérieux SA
15. Top Strategies of Key Players in the AST Market, 2023
16. Global AMR Statistics Overview, 2023 (Cases by Region)
17. Share of Automated Instruments vs. Manual Tests, 2023
18. Role of AST in Drug Development Pipeline, 2023-2032
19. Regional Snapshot of Key Market Trends, 2023
20. Investment Trends in AST Technologies, 2024-2032
This list is not complete; the final report contains over 50 figures. The list may be updated in the final deliverable.
